| Wissenschaftl. Titel | Open-labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated carcinoma of unknown primary (CUP) |
| Erkrankung |
CUP:
Cancer of unknown primary:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (FR) Weiterführende Informationen (NIH) Weiterführende Informationen (EudraCT) |
erstellt 20.10.2016 Data entry VIII CCP
geändert 17.05.2021 Data entry XI CCP